Study to Evaluate Induction of HBV Virus Neutralizing Antibodies Using VVX001

NCT03625934 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B

Interventions

BIOLOGICAL: VVX001
BIOLOGICAL: Placebo

Sponsor

Viravaxx AG

Collaborators

[object Object]
[object Object]